Article Information
History
- February 19, 2021.
Article Versions
- You are currently viewing Version 1 of this article (February 19, 2021 - 09:24).
- Version 2 (July 1, 2021 - 15:18).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Stephen M. Kissler*,1,
- Joseph R. Fauver*,2,
- Christina Mack*,3,4,
- Caroline G. Tai3,
- Mallery I. Breban2,
- Anne E. Watkins2,
- Radhika M. Samant3,
- Deverick J. Anderson5,
- David D. Ho6,
- Nathan D. Grubaugh†,2 and
- Yonatan H. Grad†,‡,1
- 1Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA
- 2Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT
- 3IQVIA, Real World Solutions, Durham, NC
- 4Department of Epidemiology, University of North Carolina-Chapel Hill, Chapel Hill, NC
- 5Duke Center for Antimicrobial Stewardship and Infection Prevention, Durham, NC
- 6Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY
- ↵‡Correspondence and requests for materials should be addressed to: Email: ygrad{at}hsph.harvard.edu, Telephone: 617.432.2275
↵* denotes equal contribution
Posted February 19, 2021.
Densely sampled viral trajectories suggest longer duration of acute infection with B.1.1.7 variant relative to non-B.1.1.7 SARS-CoV-2
